Searched for
GEORGE NAKAYAMA
The CEO who capped a $37 billion recovery with AstraZeneca dealNakayama decided to reboot Daiichi Sankyo, pivoting toward the more lucrative business of cancer drugs.- Management reshuffle at Ranbaxy ahead of Sun Pharma's takeoverThe executive committee-level changes come within months of rival drugmaker Sun Pharma agreeing to acquire Ranbaxy from its Japanese parent...
- Talented Ranbaxy executives needn’t worry: Daiichi SankyoGeorge Nakayama asked ‘talented’ executives in Ranbaxy Labs to not unduly worry about their prospects in the backdrop of the company gettin...
- Daiichi may get Japanese experts to help Ranbaxy meet USFDA normsDaiichi Sankyo may bring in additional teams of technical experts from Japan to help the former meet quality concerns raised by USFDA.
- After Tesco-Tata Deal, Anand Sharma hopes more retail majors to set up in IndiaAfter Tata-Tesco deal, minister expects more cos to invest here once they identify partners
Load More